Accenture Stock Slides to New 52-Week Low as Analysts Slash Price Targets

By TrendSpider Editor

Accenture shares are taking a significant hit today, falling 5.95% to $120.36 as two major Wall Street firms slashed their price targets, with Guggenheim cutting its target from $225 to $185 and Morgan Stanley reducing its outlook from $177 to $130. The move pushes ACN below its previous 52-week low

Accenture Stock Slides to New 52-Week Low as Analysts Slash Price Targets

Accenture shares are taking a significant hit today, falling 5.95% to $120.36 as two major Wall Street firms slashed their price targets, with Guggenheim cutting its target from $225 to $185 and Morgan Stanley reducing its outlook from $177 to $130. The move pushes ACN below its previous 52-week low of $125.60, now trading at $120.36 against a 52-week high of $317.05, meaning the stock has lost more than 62% from its annual peak. The dual target reductions, while neither firm changed its underlying rating, signal growing concern about Accenture's near-term earnings trajectory and business fundamentals.

Key Drivers of the ACN Stock Move

• Main Catalyst: Two analyst firms confirmed their existing ratings while delivering sharp price target cuts. Guggenheim's Jonathan Lee maintained a "buy" rating but slashed the target by $40, from $225 down to $185. Morgan Stanley's James Faucette held a "hold" rating with a dramatic reduction from $177 to $130, a cut of $47.
• Bull Case: Guggenheim retained its "buy" rating despite the target cut, signaling that at least one firm still sees meaningful upside from the current price of $120.36 to its revised target of $185, representing a potential gain of more than 53% if the thesis plays out.
• Bear Case: Morgan Stanley's revised price target of $130 sits only modestly above the current price of $120.36, and today's decline has already broken below the prior 52-week low of $125.60, suggesting the stock may have further room to fall with limited near-term support from the analyst community. The average price target across the two actions stands at just $157.50, a figure that reflects the broad-based deterioration in sentiment.

The forward setup for Accenture looks increasingly challenging. With the stock now printing below its 52-week floor and analyst price targets being revised lower rather than higher, bulls are facing a difficult technical and fundamental backdrop. The spread between Guggenheim's $185 target and Morgan Stanley's $130 target reflects a wide divergence in how analysts are modeling Accenture's outlook, which may keep institutional buyers cautious until there is greater clarity. The average price target of $157.50 still implies significant upside from current levels, but the direction of revisions is moving against the stock. Investors will be watching closely for any commentary from management that could stabilize sentiment or provide a catalyst for a relief rally.

ACN Analyst Ratings and Price Targets

Two analyst actions were recorded today, both confirming prior ratings while cutting price targets substantially:

• Guggenheim (Jonathan Lee): Confirmed "buy" rating. Price target reduced to $185 from a prior target of $225, a cut of $40.
• Morgan Stanley (James Faucette): Confirmed "hold" rating. Price target reduced to $130 from a prior target of $177, a cut of $47.

The average price target across both actions is $157.50. Neither firm issued an upgrade or downgrade, with zero upgrades and zero downgrades recorded among today's two total actions. However, the magnitude of the target reductions signals that both firms have meaningfully reassessed the risk and reward profile for ACN shares in the current environment.

ACN Seasonality

Late June historically marks the close of Accenture's fiscal third quarter, a period that often brings elevated volatility as investors position ahead of earnings guidance updates. Analyst target revisions arriving in the days leading into quarter-end can amplify price swings, particularly when the revisions carry the scale seen today.

ACN Relative Performance

Accenture's 5.95% single-session decline is a notable underperformer relative to the broader technology services sector on the same day. With the stock now trading at $120.36, it sits more than 62% below its 52-week high of $317.05 and has broken below its prior 52-week low of $125.60, suggesting ACN is lagging peers and the broader market significantly over a rolling twelve-month window.